Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 329 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Recruiting

Biomarkers for Risk Stratification in Lung Cancer

NCT03774758

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Zuckerberg San Francisco General Hospital and Trauma Center San Francisco, California, United States
  • San Francisco VA Medical Center San Francisco, California, United States
  • University of California, San Francisco San Francisco, California, United States
View Trial Details
Recruiting

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

NCT06917079

Conditions
Advanced Lung Carcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +34 more
Locations
  • The Angeles Clinic and Research Institute - West Los Angeles Office Los Angeles, California, United States
  • University of California Davis Sacramento, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 17 locations
View Trial Details
Recruiting

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

NCT06303505

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +22 more
Locations
  • The University of Alabama Birmingham, Alabama, United States
  • Mount Sinai New York, United States
  • Christ Hospital Cincinnati, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View all 15 locations
View Trial Details
Recruiting

Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)

NCT07079475

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Chest Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Harbin Cancer Hospital Harbin, Heilongjiang, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View all 17 locations
View Trial Details
Recruiting

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

NCT06731907

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Kentucky ( Site 0019) Lexington, Kentucky, United States
  • MedStar Franklin Square Medical Center ( Site 0033) Baltimore, Maryland, United States
  • Sanford Fargo Medical Center ( Site 0039) Fargo, North Dakota, United States
  • Abramson Cancer Center ( Site 0010) Philadelphia, Pennsylvania, United States
View all 41 locations
View Trial Details
Recruiting

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

NCT06043817

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope Huntington Beach, California, United States
  • City of Hope Irvine, California, United States
  • Levine Cancer Institute - Charlotte Charlotte, North Carolina, United States
View all 24 locations
View Trial Details

Related conditions